Nrf2 up-regulation ameliorated cognitive impairment in APP Knock-in AD mice [56], and in APPswe/PSEN1dE9 hypoxic mice, the intranasal administration of Nrf2 modulated CD36 protein expression, reduced Aβ deposition, and improved spatial memory [57]. This evidence concerns the gene CD36 and Alzheimer disease.